{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:58:58Z","timestamp":1788458338951,"version":"build-2803163510"},"reference-count":62,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1601,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2362.2011.02528.x","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T04:33:40Z","timestamp":1302842020000},"page":"1210-1219","source":"Crossref","is-referenced-by-count":10,"title":["Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction"],"prefix":"10.1111","volume":"41","author":[{"given":"Giampaolo","family":"Niccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cecchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D\u2019Amario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodosio","family":"Pafundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,14]]},"reference":[{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00395-006-0615-2","article-title":"The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion","volume":"101","author":"Raffelmann","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/01.CIR.0000016602.96363.36","article-title":"Fundamentals of reperfusion injury for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2006.05.010","article-title":"Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial","volume":"152","author":"Amit","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/eurheartj\/ehl119","article-title":"Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization","volume":"27","author":"Niccoli","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/eurheartj\/ehn325","article-title":"Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention","volume":"29","author":"Niccoli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0735-1097(97)00424-5","article-title":"Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging","volume":"31","author":"Meisel","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.lfs.2005.09.053","article-title":"Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion","volume":"78","author":"Liu","year":"2006","journal-title":"Life Sci"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2006.08.031","article-title":"Protective effects of erythropoietin in cardiac ischemia","volume":"48","author":"Lipsic","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","article-title":"A novel protective effect of erythropoietin in the infarcted heart","volume":"112","author":"Parsa","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","article-title":"Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury","volume":"18","author":"Wright","year":"2004","journal-title":"FASEB"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.tips.2008.02.002","article-title":"Erythropoietin: ready for prime-time cardioprotection","volume":"29","author":"Riksen","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.transproceed.2007.01.022","article-title":"Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?","volume":"39","author":"Menger","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11239-008-0212-3","article-title":"Erythropoietin in heart and vessels: focus on transcription and signalling pathways","volume":"26","author":"Marzo","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2009.10.028","article-title":"High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study","volume":"147","author":"Ferrario","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2009.05.050","article-title":"Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction","volume":"104","author":"Binbrek","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB19|cit19","article-title":"The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention","author":"Suh","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1253\/circj.CJ-10-0109","article-title":"Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO\/AMI-1 study","volume":"74","author":"Ozawa","year":"2010","journal-title":"Circ J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1253\/circj.CJ-10-0267","article-title":"Erythropoietin prevention trial of coronary restenosis and cardiac remodelling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study","volume":"74","author":"Taniguchi","year":"2010","journal-title":"Circ J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCINTERVENTIONS.109.904425","article-title":"REVIVAL-3 Study Investigators. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial","volume":"3","author":"Ott","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/eurheartj\/ehq304","article-title":"A single dose of erythropoietin in ST-elevation myocardial infarction","volume":"31","author":"Voors","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11239-009-0363-x","article-title":"Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)","volume":"28","author":"Andreotti","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2005.01.043","article-title":"High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention","volume":"45","author":"Namiuchi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2009.02.003","article-title":"Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome","volume":"143","author":"Szummer","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB27|cit27","first-page":"459","article-title":"Increased levels of erythropoietin in the initial phase of acute myocardial infarction","volume":"14","author":"Ant\u00f3n Mart\u00ednez","year":"1997","journal-title":"An Med Interna"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehm065","article-title":"Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction","volume":"28","author":"Ferrario","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group","volume":"312","author":"TIMI Study Group","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","article-title":"Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group","volume":"97","author":"Van\u2019t Hof","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ahj.2003.12.044","article-title":"Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction","volume":"148","author":"Gibson","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0735-1097(85)80380-6","article-title":"Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects","volume":"5","author":"Rentrop","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.103.21.2550","article-title":"Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy","volume":"103","author":"Gibson","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(01)06577-1","article-title":"Extent of ST-segment deviation in a single electrocardiogram lead 90\u2003min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction","volume":"358","author":"Schroder","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0735-1097(01)01405-X","article-title":"Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction","volume":"38","author":"Iwakura","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin\u2019s extrahematopoietic functions: biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cardiores.2004.11.019","article-title":"Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia\/reperfusion via induction of AP-1","volume":"65","author":"Rui","year":"2005","journal-title":"Card Res"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lfs.2008.12.025","article-title":"Pharmacological preconditioning with erythropoietin reduces ischemia-reperfusion injury in the small intestine of rats","volume":"84","author":"Sayan","year":"2009","journal-title":"Life Sci"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1159\/000065044","article-title":"Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in continuous ambulatory dialysis patients","volume":"91","author":"Shurtz-Swirski","year":"2002","journal-title":"Nephron"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/3-540-26560-0_120","article-title":"Erythropoietin: doping fur die elektive Weichteilchirurgie","volume":"34","author":"Contaldo","year":"2005","journal-title":"Chir Forum"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2003-04-1284","article-title":"Erythropoietin regulates endothelial progenitor cells","volume":"103","author":"Bahlmann","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2007.09.039","article-title":"Effects of darbEPOetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas\/Fas ligand system in anemic patients with chronic heart failure","volume":"199","author":"Kourea","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/092986706777935221","article-title":"Prognostic value of leukocytosis in acute coronary syndromes: the cinderella of the inflammatory markers","volume":"13","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.106.085704","article-title":"Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin","volume":"49","author":"d\u2019Uscio","year":"2007","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1046\/j.1523-1755.2000.00039.x","article-title":"Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity","volume":"57","author":"Banerjee","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.1073\/pnas.97.21.11609","article-title":"Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin","volume":"97","author":"Ruschitzka","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","article-title":"Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells","volume":"104","author":"Beleslin-Cokic","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejcts.2008.12.049","article-title":"Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production","volume":"35","author":"Mihov","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.CP0070058","article-title":"A new approach for evaluating renal function and its practical application","volume":"105","author":"Tanaka","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/japplphysiol.90578.2008","article-title":"Variations within oxygen-regulated gene expression in humans","volume":"106","author":"Brooks","year":"2009","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","article-title":"New avenues of exploration for erythropoietin","volume":"293","author":"Maiese","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.amjcard.2007.01.045","article-title":"Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention","volume":"99","author":"Porto","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1161\/CIRCULATIONAHA.108.843680","article-title":"Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction","volume":"120","author":"Deuse","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13651820410026077","article-title":"The protective effect of erythropoietin on ischaemia\/reperfusion injury of liver","volume":"6","author":"Yilmaz","year":"2004","journal-title":"HPB (Oxford)"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB61|cit61","first-page":"78","article-title":"Inflammatory mediators of liver ischemia-reperfusion injury","volume":"7","author":"Walsh","year":"2009","journal-title":"Exp Clin Transplant"},{"key":"10.1111\/j.1365-2362.2011.02528.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjcard.2007.03.075","article-title":"Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction","volume":"100","author":"Hong","year":"2007","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2011.02528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2011.02528.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T01:24:47Z","timestamp":1625361887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2011.02528.x"}},"subtitle":["ERYTHROPOIETIN AND NO-REFLOW"],"short-title":[],"issued":{"date-parts":[[2011,4,14]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02528.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,14]]}}}